• BG IRIS Research Client Login
logo
  • Home
  • Services
    • Investment Banking
      • Our transactions
      • Private Placements
      • Public Offerings
      • M&A for private companies
      • M&A for public companies
    • Capital Markets
      • Institutional Sales
      • Derivatives Sales & Trading
    • Research
      • Equity Research
      • Corporate Research
      • Equity Research login
    • Sectors
      • Healthcare
      • Software
      • Energy Transition & Sustainability
      • Industrial Tech
      • NextGen Consumer
      • Business & Tech-enabled Services
  • Company news
  • BG IRIS
  • Events
  • About us
    • About us
    • Senior team
    • Contact Us
  • Careers
    • Our vacancies
    • Our Investment Banking Positions
    • Current Equity Sales & Research Positions
    • Current Support Team Offerings
    • Current Internship Offerings
  • 25 YEARS
  • Search
  • BG IRIS Research Client Login

Our transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

  • All
  • Healthcare
  • Software
  • Industrial Tech
  • Energy Transition & Sustainability
  • Business & Tech-enabled Services
  • NextGen Consumer
  • M&A
  • Private Placements
  • ECM

Bryan, Garnier & Co acts as Sole Financial Advisor to Mint Media and its shareholders on the sale of Mint Media to Aleven

Bryan, Garnier & Co acts as Financial Advisor & Placement Agent on Abivax’s EUR 130 million Cross-over Financing

Bryan, Garnier & Co acts as Sole Financial Advisor to the Shareholders of Däckskiftarna in the merger with Bythjul, a portfolio company of French investment group Mobivia

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on a €20m secondary offering of HRS shares

Bryan, Garnier & Co acts as Sole Financial Advisor to Selfapy, one of the leading providers in digital therapeutics for mental health disorders in Germany, on its growth financing from strategic investor Medice Arzneimittel and existing shareholders

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Egetis Therapeutics’ Nasdaq Stockholm SEK 210 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to Indosuez Wealth Management on the acquisition of Wealth Dynamix

Bryan, Garnier & Co advises Carlyle on its investment in Groupe Lacour

Bryan, Garnier & Co acts as Sole Bookrunner on Oncodesign Precision Medicine’s EUR 8 million Follow-on Offering & IPO on Euronext Growth Paris

Bryan, Garnier & Co acts as Sole Financial Advisor to XVIVO on the acquisition of the Machine & Perfusion division from Avionord S.r.l.

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Nicox’ Euronext Paris EUR 10 million Follow-on Offering & Warrants issuance

Bryan, Garnier & Co acts as Sole Financial Advisor to the software company Groupe Positive (ex- Groupe Sarbacane) and its shareholders on its €110m fundraise led by EMZ

Bryan, Garnier & Co acts as Sole Financial Advisor to Kaliti and its shareholders on the sale to Meanings

Bryan, Garnier & Co acts as Sole Financial Advisor to the digital-native staffing platform Gojob on its €23 million Series C fundraise

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Braincourt GmbH, a leading full-service management consultancy with a focus on Business Intelligence, Data Science and Project & Organisational Experience, on the sale of the Company to the listed Capgemini

Bryan, Garnier & Co acted as the Financial Advisor to Shark Solutions, global leader in manufacturing recycled PVB post consumer use, successfully completing the Company’s €20m private placements led by AXA Investment Managers Alts’ Impact Fund

Bryan, Garnier & Co acts as Sole Financial Advisor to Ekoscan Integrity and its shareholders on its €23m fundraising from private equity firm Abénex, alongside new and historical strategics (EDF Pulse and ALIAD, the innovative investment arms of EDF and Air Liquide respectively)

Bryan, Garnier & Co acts as Joint Bookrunner on Valneva’s Nasdaq and Euronext Paris EUR 102.9 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to Partyking and its shareholders on the sale of the Company to Amscan International

Bryan, Garnier & Co acts as Sole Financial Advisor to the Shareholders of Groupe Artemys, IT services specialist, on its acquisition of AJS Formation

Bryan, Garnier & Co acted as sole financial advisor to Mailinblack and its shareholders on the LBO led by Apax Partners alongside New Alpha Verto, management and historical shareholders

Bryan, Garnier & Co acted as Sole Financial Advisor to New Alpha Verto on its investment in GAC Technology

Bryan, Garnier & Co acts as Sole Global Coordinator and Joint Bookrunner on Abivax’s EUR 49 million Cross-over Financing

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders, Altana AG and Hans Mathea, founder and CEO of dp polar GmbH, a leading developer and producer of 3D printing systems for industrial series production on the sale of the Company to NYSE-listed 3D Systems

Bryan, Garnier & Co acts as Sole Financial Advisor to Ganymed Robotics, a developer of computer vision software and robotics technologies for orthopedic surgeons, on its first €21 million closing of its oversubscribed Fundraising

Bryan, Garnier & Co acts as Sole Financial Advisor to Oncodesign on the sale of its CRO activities to Elyan Partners for €100m and the concomitant spin-off of its Biotech/AI activities

Deal Agile MV

Bryan, Garnier & Co acted as Sole Financial Advisor to Vade and its shareholders on its €28m fundraising from Tikehau Ace Capital, Bpifrance and Auriga Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to the Management of Astrocast, leading global IoT satellite operator, on its contemplated acquisition of Hiber

Bryan, Garnier & Co acts as Sole Financial Advisor to Laurent Blanc and Phillimore, shareholders of the design and lifestyle media group Ideat Editions, on its contemplated sale to I/O Media

Bryan Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Lhyfe on its landmark €110m IPO on Euronext Paris

Bryan, Garnier & Co acts as Sole Financial Advisor to Enapter AG on a €20m strategic investment from Johnson Matthey

Bryan, Garnier & Co acts as Sole Financial Advisor to Bridgepoint Development Capital on their contemplated investment in CAST

Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on GeNeuro EUR 7.7 million Follow-On Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the Sellers of Våning 18 to Äleven

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Grundium Oy on the sale of a majority stake to EW Healthcare Partners

Bryan, Garnier & Co advises Qualium Investissement on its acquisition of Recocash from IK Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to Capza and the Management of Horizon Software, leading electronic trading software provider, on the contemplated sale of the Company to Sagard NewGen

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Avantium’s Euronext Amsterdam EUR 45m Publicly Marketed Follow-On Offering

Deal Terranova Security

Bryan, Garnier & Co acts as Sole Financial Advisor to Protix on its €50 million Fundraising

Bryan, Garnier & Co advises Cathay Capital, Sagard NewGen and Eurazeo on their investment in DiliTrust

Bryan, Garnier & Co acts as Sole Financial Advisor and Sole Placement Agent to the leading geo-analytics company Kayrros on its €40 million Series C financing from New Space Capital, Bpifrance, Opera Tech Ventures (BNP Paribas VC arm), EIB and existing shareholders

Bryan, Garnier & Co acts as Sole Financial Advisor to Praxedo and its founders on a growth LBO led by MBO & Co

Bryan, Garnier & Co acts as Exclusive Financial Advisor to the shareholders and founders of kompany on the sale of the company to Moody’s

Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of Sword GRC to Riskonnect, a portfolio company of TA Associates

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Aelis Farma’s Euronext Paris EUR 25m Initial Public Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to clinical-stage biologics company BiosanaPharma on its global strategic partnership with Alvotech

Bryan, Garnier & Co acts as Sole Financial Advisor to Padoa and its shareholders on the investment of Five Arrows Growth Capital

Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CyberCité, a SEO and SEA agency, on the sale of the Company to Isoskele, part of Groupe La Poste

Bryan, Garnier & Co acts as Sole Financial Advisor to MNH on the sale of AKLIA to Hoppen

Bryan, Garnier & Co is proud to act as Joint Bookrunner to Cell Impact on its SEK 349m Rights Issue

  • 1
  • 2
  • 3
  • …
  • 10
Menu

Home

All transactions

Investment Banking

Capital Markets

Sectors

Our Insights

Other

Events

Our team

Careers

About us

Press

Contact us

Legal

  • Legal Information
  • Index 2022
  • Bryan Garnier Securities
  • Privacy Policy

Latest News

  • Falk Mueller-Veerse, Partner & Head of DACH at Bryan, Garnier & Co, presided the selection panel of the Tech Tour Growth50 for the 2023 edition
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
SAVE & ACCEPT

Privacy Preference Center

Privacy Preferences